Small Role with Big Impact: MiRNAs As Communicators in the Cross-talk Between Cancer-associated Fibroblasts and Cancer Cells

Overview

Journal Int J Biol Sci

Specialty Biology

Date 2017 Apr 4

PMID 28367098

Citations 21

Authors

Zhanhuai Wang

Yinuo Tan

Wei Yu

Shu Zheng

Suzhan Zhang

Lifeng Sun

Kefeng Ding

Affiliations

Soon will be listed here.

Abstract

Cancer microenvironment is composed of numerous components that can support cancer cell proliferation, promote cancer progression and contribute to cancer treatment resistance. The major components of caner microenvironment are fibroblasts, endothelial cells, immune cells as well as cytokines, chemokines, and extracellular matrix (ECM) all of which surround tumor cells as the core and cross talk with each other. Among them, cancer-associated fibroblasts (CAFs) play an important role in promoting cancer progression by secreting various pro-inflammatory factors. MicroRNAs (miRNAs) are small noncoding RNAs that negatively regulate protein expression both in cancer cell and normal stromal cells. Changes of miRNAs expression in cancer-associated fibroblasts can be induced both by cancer cells and other stromal cells. This change can arise through direct interaction or by secreted paracrine factors or even by secreted miRNAs. The desregulated miRNAs in cancer-associated fibroblasts then enhance the CAFs phenotype and assist their cancer promotion ability. Explore the regulatory function of miRNAs in the complex communication between cancer cells and cancer microenvironment is important to understand the process of tumor progression and may help to develop new therapeutic strategies. This review provides an updated content of latest research advances about the relevance of miRNAs in the interaction between cancer cells and the CAFs. We will describe miRNAs which are differential expressed by NFs and CAFs, their function in regulating fibroblasts activation as well as miRNAs expressed in CAFs as prognostic factors in cancer stroma in recent studies. We will also discuss miRNA as an important player in CAFs mediated regulation of cancer progression and metastasis cancer metabolism, cancer stem cell property and chemoresistance.

Citing Articles

Senescence-Associated miRNAs and Their Role in Pancreatic Cancer.

Popov A, Mandys V Pathol Oncol Res. 2022; 28:1610156.

PMID: 35570840 PMC: 9098800. DOI: 10.3389/pore.2022.1610156.

Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts.

Zhang C, Wang X, Zhang P, He T, Han J, Zhang R Cell Death Dis. 2022; 13(1):57.

PMID: 35027547 PMC: 8758774. DOI: 10.1038/s41419-022-04506-4.

Propensity for Early Metastatic Spread in Breast Cancer: Role of Tumor Vascularization Features and Tumor Immune Infiltrate.

Dandrea M, Cereda V, Coppola L, Giordano G, Remo A, De Santis E Cancers (Basel). 2021; 13(23).

PMID: 34885027 PMC: 8657227. DOI: 10.3390/cancers13235917.

MiR-125a-3p inhibits cell proliferation and inflammation responses in fibroblast-like synovial cells in rheumatoid arthritis by mediating the Wnt/β-catenin and NF-κB pathways via targeting MAST3.

Wang Y, Yin Z, Zhang N, Song H, Zhang Q, Hao X J Musculoskelet Neuronal Interact. 2021; 21(4):560-567.

PMID: 34854396 PMC: 8672414.

Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response.

Rickard B, Conrad C, Sorrin A, Ruhi M, Reader J, Huang S Cancers (Basel). 2021; 13(17).

PMID: 34503128 PMC: 8430600. DOI: 10.3390/cancers13174318.

References

McAllister S, Weinberg R . The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014; 16(8):717-27. PMC: 6220424. DOI: 10.1038/ncb3015. View

Hu J, Sun P, Zhang D, Xiong W, Mi J . Hexokinase 2 regulates G1/S checkpoint through CDK2 in cancer-associated fibroblasts. Cell Signal. 2014; 26(10):2210-6. DOI: 10.1016/j.cellsig.2014.04.015. View

Tominaga N, Katsuda T, Ochiya T . Micromanaging of tumor metastasis by extracellular vesicles. Semin Cell Dev Biol. 2015; 40:52-9. DOI: 10.1016/j.semcdb.2015.02.016. View

Paulsson J, Micke P . Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin Cancer Biol. 2014; 25:61-8. DOI: 10.1016/j.semcancer.2014.02.006. View

Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K . MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci. 2013; 105(2):228-35. PMC: 4317817. DOI: 10.1111/cas.12329. View

Suzuki H, Katsura A, Matsuyama H, Miyazono K . MicroRNA regulons in tumor microenvironment. Oncogene. 2014; 34(24):3085-94. PMC: 4761641. DOI: 10.1038/onc.2014.254. View

Clark J, Thomas D, Choong P, Dass C . RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev. 2007; 26(3-4):675-83. DOI: 10.1007/s10555-007-9093-8. View

Ito M, Ishii G, Nagai K, Maeda R, Nakano Y, Ochiai A . Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma. Chest. 2012; 142(1):151-158. DOI: 10.1378/chest.11-2458. View

Polanska U, Orimo A . Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol. 2013; 228(8):1651-7. DOI: 10.1002/jcp.24347. View

10.

Hu M, Yao J, Cai L, Bachman K, van den Brule F, Velculescu V . Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 2005; 37(8):899-905. DOI: 10.1038/ng1596. View

11.

Bronisz A, Godlewski J, Wallace J, Merchant A, Nowicki M, Mathsyaraja H . Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol. 2011; 14(2):159-67. PMC: 3271169. DOI: 10.1038/ncb2396. View

12.

Al-Ansari M, Aboussekhra A . miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts. Oncotarget. 2015; 6(30):30006-16. PMC: 4745778. DOI: 10.18632/oncotarget.4933. View

13.

Hasegawa T, Yashiro M, Nishii T, Matsuoka J, Fuyuhiro Y, Morisaki T . Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling. Int J Cancer. 2013; 134(8):1785-95. DOI: 10.1002/ijc.28520. View

14.

Li P, Shan J, Chen X, Zhang D, Su L, Huang X . Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment. Cell Res. 2015; 25(5):588-603. PMC: 4423088. DOI: 10.1038/cr.2015.51. View

15.

Konig A, Menzel T, Lynen S, Wrazel L, Rosen A, Al-Katib A . Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis. Leukemia. 1997; 11(2):258-65. DOI: 10.1038/sj.leu.2400556. View

16.

Kohlhapp F, Mitra A, Lengyel E, Peter M . MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene. 2015; 34(48):5857-68. PMC: 4604012. DOI: 10.1038/onc.2015.89. View

17.

Morello M, Minciacchi V, de Candia P, Yang J, Posadas E, Kim H . Large oncosomes mediate intercellular transfer of functional microRNA. Cell Cycle. 2013; 12(22):3526-36. PMC: 3906338. DOI: 10.4161/cc.26539. View

18.

Donahue T, Nguyen A, Moughan J, Li L, Tatishchev S, Toste P . Stromal microRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer. J Surg Oncol. 2014; 110(8):952-9. PMC: 4232442. DOI: 10.1002/jso.23750. View

19.

Peschiaroli A, Giacobbe A, Formosa A, Markert E, Bongiorno-Borbone L, Levine A . miR-143 regulates hexokinase 2 expression in cancer cells. Oncogene. 2012; 32(6):797-802. DOI: 10.1038/onc.2012.100. View

20.

Bullock M, Pickard K, Nielsen B, Sayan A, Jenei V, Mellone M . Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis. 2013; 4:e684. PMC: 3702298. DOI: 10.1038/cddis.2013.213. View